Quantifying the expected vs potential impact of a risk-factor intervention program.
Bulterys
M
M
Morgenstern
H
H
Weed
D L
DL
D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D009436:Neural Tube Defects / Q000453:epidemiology / Q000517:prevention & control; D015397:Program Evaluation / Q000379:methods*; D012306:Risk; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D005492:Folic Acid